MX2020006881A - Sistemas y metodos para tratar fluidos biologicos. - Google Patents

Sistemas y metodos para tratar fluidos biologicos.

Info

Publication number
MX2020006881A
MX2020006881A MX2020006881A MX2020006881A MX2020006881A MX 2020006881 A MX2020006881 A MX 2020006881A MX 2020006881 A MX2020006881 A MX 2020006881A MX 2020006881 A MX2020006881 A MX 2020006881A MX 2020006881 A MX2020006881 A MX 2020006881A
Authority
MX
Mexico
Prior art keywords
systems
methods
biological fluids
treating biological
treating
Prior art date
Application number
MX2020006881A
Other languages
English (en)
Inventor
Adonis Stassinopoulos
Peter Bringmann
Maria Felicia Santa
Daniel Church
Grace Castro
Thea Lu
Shelby Reinhardt
Original Assignee
Cerus Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cerus Corp filed Critical Cerus Corp
Publication of MX2020006881A publication Critical patent/MX2020006881A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
    • A61L2/0029—Radiation
    • A61L2/0047—Ultraviolet radiation
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02—Preservation of living parts
    • A01N1/0205—Chemical aspects
    • A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
    • A01N1/0215—Disinfecting agents, e.g. antimicrobials for preserving living parts
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02—Preservation of living parts
    • A01N1/0278—Physical preservation processes
    • A01N1/0294—Electromagnetic, i.e. using electromagnetic radiation or electromagnetic fields
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A61K31/37—Coumarins, e.g. psoralen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/10—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person
    • A61K41/17—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person by ultraviolet [UV] or infrared [IR] light, X-rays or gamma rays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
    • A61L2/0029—Radiation
    • A61L2/0076—Radiation using a photocatalyst or photosensitiser
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/02—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
    • A61L2/08—Radiation
    • A61L2/10—Ultraviolet radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/16—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/26—Accessories or devices or components used for biocidal treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3681—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by irradiation
    • A61M1/3683—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by irradiation using photoactive agents
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J19/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J19/08—Processes employing the direct application of electric or wave energy, or particle radiation; Apparatus therefor
    • B01J19/12—Processes employing the direct application of electric or wave energy, or particle radiation; Apparatus therefor employing electromagnetic waves
    • B01J19/122—Incoherent waves
    • B01J19/123—Ultraviolet light
    • H—ELECTRICITY
    • H01—ELECTRIC ELEMENTS
    • H01L—SEMICONDUCTOR DEVICES NOT COVERED BY CLASS H10
    • H01L25/00—Assemblies consisting of a plurality of individual semiconductor or other solid state devices ; Multistep manufacturing processes thereof
    • H01L25/03—Assemblies consisting of a plurality of individual semiconductor or other solid state devices ; Multistep manufacturing processes thereof all the devices being of a type provided for in the same subgroup of groups H01L27/00 - H01L33/00, or in a single subclass of H10K, H10N, e.g. assemblies of rectifier diodes
    • H01L25/04—Assemblies consisting of a plurality of individual semiconductor or other solid state devices ; Multistep manufacturing processes thereof all the devices being of a type provided for in the same subgroup of groups H01L27/00 - H01L33/00, or in a single subclass of H10K, H10N, e.g. assemblies of rectifier diodes the devices not having separate containers
    • H01L25/075—Assemblies consisting of a plurality of individual semiconductor or other solid state devices ; Multistep manufacturing processes thereof all the devices being of a type provided for in the same subgroup of groups H01L27/00 - H01L33/00, or in a single subclass of H10K, H10N, e.g. assemblies of rectifier diodes the devices not having separate containers the devices being of a type provided for in group H01L33/00
    • H—ELECTRICITY
    • H01—ELECTRIC ELEMENTS
    • H01L—SEMICONDUCTOR DEVICES NOT COVERED BY CLASS H10
    • H01L25/00—Assemblies consisting of a plurality of individual semiconductor or other solid state devices ; Multistep manufacturing processes thereof
    • H01L25/03—Assemblies consisting of a plurality of individual semiconductor or other solid state devices ; Multistep manufacturing processes thereof all the devices being of a type provided for in the same subgroup of groups H01L27/00 - H01L33/00, or in a single subclass of H10K, H10N, e.g. assemblies of rectifier diodes
    • H01L25/04—Assemblies consisting of a plurality of individual semiconductor or other solid state devices ; Multistep manufacturing processes thereof all the devices being of a type provided for in the same subgroup of groups H01L27/00 - H01L33/00, or in a single subclass of H10K, H10N, e.g. assemblies of rectifier diodes the devices not having separate containers
    • H01L25/075—Assemblies consisting of a plurality of individual semiconductor or other solid state devices ; Multistep manufacturing processes thereof all the devices being of a type provided for in the same subgroup of groups H01L27/00 - H01L33/00, or in a single subclass of H10K, H10N, e.g. assemblies of rectifier diodes the devices not having separate containers the devices being of a type provided for in group H01L33/00
    • H01L25/0753—Assemblies consisting of a plurality of individual semiconductor or other solid state devices ; Multistep manufacturing processes thereof all the devices being of a type provided for in the same subgroup of groups H01L27/00 - H01L33/00, or in a single subclass of H10K, H10N, e.g. assemblies of rectifier diodes the devices not having separate containers the devices being of a type provided for in group H01L33/00 the devices being arranged next to each other
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/24—Apparatus using programmed or automatic operation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2202/00—Aspects relating to methods or apparatus for disinfecting or sterilising materials or objects
    • A61L2202/10—Apparatus features
    • A61L2202/11—Apparatus for generating biocidal substances, e.g. vaporisers, UV lamps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2202/00—Aspects relating to methods or apparatus for disinfecting or sterilising materials or objects
    • A61L2202/10—Apparatus features
    • A61L2202/12—Apparatus for isolating biocidal substances from the environment
    • A61L2202/122—Chambers for sterilisation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2202/00—Aspects relating to methods or apparatus for disinfecting or sterilising materials or objects
    • A61L2202/10—Apparatus features
    • A61L2202/14—Means for controlling sterilisation processes, data processing, presentation and storage means, e.g. sensors, controllers, programs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2202/00—Aspects relating to methods or apparatus for disinfecting or sterilising materials or objects
    • A61L2202/20—Targets to be treated
    • A61L2202/22—Blood or products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/04—Liquids
    • A61M2202/0413—Blood
    • A61M2202/0415—Plasma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/04—Liquids
    • A61M2202/0413—Blood
    • A61M2202/0427—Platelets; Thrombocytes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Electromagnetism (AREA)
  • Power Engineering (AREA)
  • Microelectronics & Electronic Packaging (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Dentistry (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Organic Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Condensed Matter Physics & Semiconductors (AREA)
  • Computer Hardware Design (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • External Artificial Organs (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Se proporcionan sistemas y métodos para tratar un fluido biológico, por ejemplo, para inactivar patógenos.
MX2020006881A 2017-12-29 2018-12-28 Sistemas y metodos para tratar fluidos biologicos. MX2020006881A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762612314P 2017-12-29 2017-12-29
PCT/US2018/068048 WO2019133929A1 (en) 2017-12-29 2018-12-28 Systems and methods for treating biological fluids

Publications (1)

Publication Number Publication Date
MX2020006881A true MX2020006881A (es) 2020-10-01

Family

ID=65139275

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2020006881A MX2020006881A (es) 2017-12-29 2018-12-28 Sistemas y metodos para tratar fluidos biologicos.
MX2023006058A MX2023006058A (es) 2017-12-29 2020-07-13 Sistemas y metodos para tratar fluidos biologicos.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2023006058A MX2023006058A (es) 2017-12-29 2020-07-13 Sistemas y metodos para tratar fluidos biologicos.

Country Status (15)

Country Link
US (2) US11554185B2 (es)
EP (1) EP3731960A1 (es)
JP (2) JP7311518B2 (es)
KR (1) KR20200115498A (es)
CN (2) CN111770789B (es)
AU (1) AU2018395525B2 (es)
BR (1) BR112020013178A2 (es)
CA (1) CA3087253A1 (es)
CO (1) CO2020009340A2 (es)
EA (1) EA202091602A1 (es)
IL (1) IL275698B2 (es)
MX (2) MX2020006881A (es)
SG (1) SG11202006158TA (es)
TW (1) TWI821233B (es)
WO (1) WO2019133929A1 (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016210374A1 (en) 2015-06-26 2016-12-29 Cerus Corporation Cryoprecipitate compositions and methods of preparation thereof
CA3003097A1 (en) 2015-10-23 2017-04-27 Cerus Corporation Plasma compositions and methods of use thereof
BR112019018273A2 (pt) 2017-03-03 2020-07-14 Cerus Corporation kits e métodos para preparação de composições de plaquetas inativadas por patógenos
TWI728589B (zh) * 2019-12-12 2021-05-21 國立臺灣大學 以熱作用於活體組織的方法及裝置
EP3986499A2 (en) 2019-06-22 2022-04-27 Cerus Corporation Biological fluid treatment systems
US11498046B2 (en) * 2019-06-27 2022-11-15 Phoseon Technology, Inc. Method and system for tetrachloromethane synthesis
EP3991179A1 (en) 2019-06-28 2022-05-04 Cerus Corporation System and methods for implementing a biological fluid treatment device
CN111840596B (zh) * 2020-06-11 2022-03-11 南岳生物制药有限公司 核黄素光化学血浆灭活装置及其控制系统、控制方法
EP3957333A1 (de) * 2020-08-19 2022-02-23 Analytik Jena GmbH Uv-modul, system und verfahren zur deaktivierung von biologisch kontaminierten oberflächen in einem inneraum eines geräts
EP4230237A4 (en) * 2020-10-14 2024-04-17 Otsuka Electronics Co., Ltd. PHOTODYNAMIC THERAPY DEVICE COMPRISING A BLOOD COOLING WATER CIRCULATION UNIT
IL302136A (en) 2020-10-19 2023-06-01 Cerus Corp Modular light fixture for biological fluid treatment system
CN112316166B (zh) * 2020-10-30 2022-07-12 中国医学科学院输血研究所 一种生物液体样本中病原体的核黄素光化学灭活方法
US20240082441A1 (en) * 2021-01-21 2024-03-14 Signify Holding B.V. A light emitting system for disinfecting a target area
US20220354140A1 (en) * 2021-05-05 2022-11-10 Saltbrick Retail, LLC Process for dry aging meat
CN113877485A (zh) * 2021-10-18 2022-01-04 江苏汉邦科技有限公司 一种核酸合成仪
FR3138040A1 (fr) 2022-07-21 2024-01-26 Maco Pharma Appareil et procédé pour irradier un fluide biologique
AT526979A1 (de) * 2023-02-28 2024-09-15 Sallinger Mst Eur Ing Peter Vorrichtung, Verfahren und Anordnung zur Behandlung des Abfallfluids einer hämatologischen Analysevorrichtung
US11820675B1 (en) * 2023-04-21 2023-11-21 Soletluna Holdings, Inc. Device that treats water with multiple wavelengths of light
EP4450464A1 (en) * 2023-04-21 2024-10-23 Soletluna Holdings, Inc. Device that treats water with multiple wavelengths of lights and sound

Family Cites Families (131)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5556958A (en) * 1989-10-26 1996-09-17 Steritech, Inc. Inactivation of pathogens in clinical samples
US5221608A (en) 1989-10-26 1993-06-22 Cimino George D Methods for rendering amplified nucleic acid subsequently unamplifiable
US5418130A (en) * 1990-04-16 1995-05-23 Cryopharm Corporation Method of inactivation of viral and bacterial blood contaminants
US5232844A (en) 1990-05-15 1993-08-03 New York Blood Center Photodynamic inactivation of viruses in cell-containing compositions
US5167656A (en) 1991-01-22 1992-12-01 Baxter International Inc. Blood container having lay-flat sample reservoir
DE9102709U1 (de) 1991-03-07 1991-05-23 Blutspendedienst der Landesverbände des Deutschen Roten Kreuzes Niedersachsen, Oldenburg und Bremen Gemeinnützige GmbH, 3257 Springe Blutbeutelanordnung
CA2089005C (en) 1991-06-21 1999-01-19 John Chapman Method for inactivating pathogens in a body fluid
US5618662A (en) 1992-03-02 1997-04-08 Cerus Corporation Intravenous administration of psoralen
WO1996014740A1 (en) 1992-03-02 1996-05-23 Cerus Corporation Synthetic media for blood components
US5288605A (en) * 1992-03-02 1994-02-22 Steritech, Inc. Methods for inactivating bacteria in blood preparations with 8-methoxypsoralen
US5459030A (en) 1992-03-02 1995-10-17 Steritech, Inc. Synthetic media compositions for inactivating bacteria and viruses in blood preparations with 8-methoxypsoralen
US5709991A (en) 1992-03-02 1998-01-20 Cerus Corporation Proralen inactivation of microorganisms and psoralen removal
US6433343B1 (en) 1992-03-02 2002-08-13 Cerus Corporation Device and method for photoactivation
ATE192898T1 (de) 1992-08-07 2000-06-15 Cerus Corp Verfahren zur inaktivierung von bakterien in blutpräparaten mit hilfe von methoxypsoralen
FR2696095B1 (fr) 1992-09-30 1994-11-25 Inoteb Colle biologique à base de protéines coagulables par la thrombine, enrichie en facteurs plaquettaires, sa préparation et son application.
US5871900A (en) 1993-06-28 1999-02-16 Cerus Corporation Method of inactivating pathogens in biological fluids using photoactivated 5-primaryamino psoralens
US5399719A (en) 1993-06-28 1995-03-21 Steritech, Inc. Compounds for the photodecontamination of pathogens in blood
US6004741A (en) 1993-06-28 1999-12-21 Cerus Corporation Method for the photoactivation of 4' and 5' primary aminoalkyl psoralens in platelet preparations
US5593823A (en) 1993-06-28 1997-01-14 Cerus Corporation Method for inactivating pathogens in blood using photoactivation of 4'-primary amino-substituted psoralens
US6004742A (en) 1993-06-28 1999-12-21 Cerus Corporation Method for inactivation of pathogens in platelets using 4' and 5' primary amino-substituted psoralens
US6420570B1 (en) 1993-06-28 2002-07-16 Cerus Corporation Psoralen compounds
US5556993A (en) 1993-06-28 1996-09-17 Steritech, Inc. Compounds for the photodecontamination of pathogens in blood
ATE242960T1 (de) 1993-11-10 2003-07-15 Cerus Corp Vorrichtung und verfahren zur photoaktivierung
WO1996008965A1 (en) 1994-09-22 1996-03-28 Baxter International, Inc. Photodynamic inactivation of viral and bacterial blood contaminants with halogenated coumarin and furocoumarin sensitizers
US5691132A (en) 1994-11-14 1997-11-25 Cerus Corporation Method for inactivating pathogens in red cell compositions using quinacrine mustard
US6177441B1 (en) 1995-06-05 2001-01-23 Cerus Corporation Treating red blood cell solutions with anti-viral agents
WO1996039820A1 (en) 1995-06-07 1996-12-19 Cerus Corporation Methods of inactivating leukocytes and inhibiting cytokine production in blood products
CA2221605C (en) 1995-06-07 2005-10-18 Cerus Corporation Methods and devices for the removal of psoralens from blood products
EP0773716A4 (en) 1995-06-07 1999-08-04 Cerus Corp TREATMENT OF RED BLOOD CELL SOLUTIONS WITH ANTIVRAL ACTIVE SUBSTANCES
US20020192632A1 (en) 1995-06-07 2002-12-19 Hei Derek J. Method and devices for the removal of psoralens from blood products
US6544727B1 (en) 1995-06-07 2003-04-08 Cerus Corporation Methods and devices for the removal of psoralens from blood products
WO1997021346A1 (en) 1995-12-14 1997-06-19 Cerus Corporation Inactivation of non-enveloped virus
US20020115585A1 (en) 1996-06-07 2002-08-22 Hei Derek J. Method and devices for the removal of psoralens from blood products
US6190855B1 (en) 1996-10-28 2001-02-20 Baxter International Inc. Systems and methods for removing viral agents from blood
US6514987B1 (en) 1997-01-06 2003-02-04 Cerus Corporation Frangible compounds for pathogen inactivation
US20010018179A1 (en) 1998-01-06 2001-08-30 Derek J. Hei Batch devices for the reduction of compounds from biological compositions containing cells and methods of use
US20010009756A1 (en) 1998-01-06 2001-07-26 Derek Hei Flow devices for the reduction of compounds from biological compositions and methods of use
US6093725A (en) 1997-01-06 2000-07-25 Cerus Corporation Frangible compounds for pathogen inactivation
DE69827770T2 (de) 1997-01-06 2006-03-02 Cerus Corp., Concord Adsorbentien und geräte zur verminderung von kleinen organischen verbindungen aus blutprodukten
EP1021414B1 (en) 1997-01-06 2003-06-18 Cerus Corporation Frangible compounds for pathogen inactivation
CA2296366A1 (en) 1997-07-21 1999-01-28 Cerus Corporation Method of treating leukocytes, leukocyte compositions and methods of use thereof
DE69819360T2 (de) 1997-11-20 2004-08-19 Cerus Corp., Concord Neue psoralene zur inaktivierung von pathogenen
DE69826521T2 (de) 1998-01-06 2005-09-29 Cerus Corp., Concord Verfahren zum quenchen von pathogen-inaktivatoren in biologischen materialien
JP2003527230A (ja) 1998-01-06 2003-09-16 シーラス コーポレイション 生物学的組成物からの化合物の減少のためのフローデバイスおよびその使用方法
US7611831B2 (en) 1998-01-06 2009-11-03 Cerus Corporation Adsorbing pathogen-inactivating compounds with porous particles immobilized in a matrix
AU4435399A (en) 1998-06-11 1999-12-30 Cerus Corporation Inhibiting proliferation of arterial smooth muscle cells
US6277337B1 (en) 1998-07-21 2001-08-21 Gambro, Inc. Method and apparatus for inactivation of biological contaminants using photosensitizers
US6565802B1 (en) * 1999-06-03 2003-05-20 Baxter International Inc. Apparatus, systems and methods for processing and treating a biological fluid with light
US7445756B2 (en) 1999-06-03 2008-11-04 Fenwal, Inc. Fluid processing sets and organizers for the same
US7068361B2 (en) 1999-06-03 2006-06-27 Baxter International Apparatus, systems and methods for processing and treating a biological fluid with light
US7025877B1 (en) 1999-06-03 2006-04-11 Baxter International Inc. Processing set for processing and treating a biological fluid
US6494753B1 (en) 1999-08-02 2002-12-17 Swenco Products, Inc. No-crimp electrical connector side-by-side type and method
US20020042043A1 (en) 2000-05-31 2002-04-11 Adonis Stassinopoulos Preparation of a pathogen inactivated solution of red blood cells having reduced immunogenicity
US6843961B2 (en) 2000-06-15 2005-01-18 Gambro, Inc. Reduction of contaminants in blood and blood products using photosensitizers and peak wavelengths of light
JP4412441B2 (ja) 2000-07-11 2010-02-10 日本電気株式会社 液晶表示装置
AU2007237275A1 (en) * 2000-11-13 2008-01-10 Bayer Aktiengesellschaft Method of inactivating microorganisms in a fluid using ultraviolet radiation
AU2001298078A1 (en) 2000-12-21 2003-09-02 Cerus Corporation Methods for inactivation of pathogens in biological materials
US7381976B2 (en) * 2001-03-13 2008-06-03 Triton Thalassic Technologies, Inc. Monochromatic fluid treatment systems
US20030207247A1 (en) 2001-12-05 2003-11-06 Cerus Corporation Preparation of red blood cells having reduced immunogenicity
US7264608B2 (en) 2001-12-05 2007-09-04 Fenwal, Inc. Manual processing systems and methods for providing blood components conditioned for pathogen inactivation
JP2006502964A (ja) 2002-02-06 2006-01-26 ジョンズ ホプキンス ユニバーシティ スクール オブ メディシン 特定の器官または組織に対する全身性免疫応答の標的化のための方法および組成物
JP2005519744A (ja) 2002-03-14 2005-07-07 バクスター・インターナショナル・インコーポレイテッド 化合物除去器
AU2003221787A1 (en) 2002-04-26 2003-11-10 Gambro, Inc. Solution containing platelet activation inhibitors for pathogen reducing and storing blood platelets
EP1575500A4 (en) 2002-07-12 2007-01-03 Univ Johns Hopkins MESOTHELIN VACCINE AND MODEL SYSTEMS
AU2003270007A1 (en) * 2002-08-23 2004-03-11 Gambro, Inc. Nucleic acid damage using riboflavin and light
US20040088189A1 (en) 2002-11-06 2004-05-06 Veome Edmond A. System and method for monitoring , reporting, managing and administering the treatment of a blood component
AU2003298827A1 (en) 2002-12-04 2004-06-23 Cerus Corporation Methods for preparing antigen masked red blood cells having reduced hemolysis by sera
US7695725B2 (en) 2003-02-06 2010-04-13 Aduro Biotech Modified free-living microbes, vaccine compositions and methods of use thereof
JP4545151B2 (ja) 2003-02-06 2010-09-15 シーラス コーポレイション 非食細胞中への侵入について減弱化されているリステリア、そのリステリアを含むワクチン、およびそれらの使用法
KR101173871B1 (ko) 2003-02-06 2012-08-16 앤저 테라퓨틱스 인코퍼레이티드 변형된 독립생존 미생물, 백신 조성물 및 그것의 사용방법
DE10323843A1 (de) 2003-05-23 2004-12-23 Fresenius Medical Care Deutschland Gmbh Blutbehandlungsgerät
GB0313742D0 (en) 2003-06-13 2003-07-16 Curry Charles E Valve diagnostic tool
AU2004281834A1 (en) 2003-10-15 2005-04-28 Cerus Corporation Listeria-based EphA2 vaccines
EP1732580A4 (en) 2003-12-24 2008-01-23 Medimmune Inc EPHA2 VACCINES
US7842289B2 (en) 2003-12-24 2010-11-30 Aduro Biotech Recombinant nucleic acid molecules, expression cassettes, and bacteria, and methods of use thereof
AU2004314347B2 (en) 2003-12-24 2011-05-19 Aduro Biotech, Inc. Recombinant nucleic acid molecules encoding fusion proteins comprising antigens and bacterial secretory signal polypeptides, expression cassettes, and bacteria, and methods of use thereof
WO2005092372A2 (en) 2004-02-06 2005-10-06 Cerus Corporation Modified bacillus anthracis vaccine compositions and methods of use thereof
US20070031457A1 (en) 2004-02-06 2007-02-08 Dubensky Thomas W Jr Modified Bacillus anthracis, vaccine compositions and methods of use thereof
US8296071B2 (en) 2004-03-15 2012-10-23 Terumo Bct Biotechnologies, Llc Methods for uniformly treating biological samples with electromagnetic radiation
EP1838355B1 (en) 2004-10-29 2013-08-14 Cerus Corporation Improved quenching methods for red blood cell inactivation process
US20070190063A1 (en) 2005-08-19 2007-08-16 Bahjat Keith S Antibody-mediated enhancement of immune response
TW200811289A (en) 2005-08-19 2008-03-01 Cerus Corp Listeria-mediated immunorecruitment and activation, and methods of use thereof
US20070207171A1 (en) 2006-03-01 2007-09-06 Cerus Corporation Engineered listeria and methods of use thereof
WO2007103261A2 (en) 2006-03-01 2007-09-13 Medimmune, Inc. Listeria-based epha2 immunogenic compositions
US7935804B2 (en) 2006-03-01 2011-05-03 Aduro Biotech Engineered Listeria and methods of use thereof
WO2007117371A2 (en) 2006-03-01 2007-10-18 Anza Therapeutics, Inc. Engineered listeria and methods of use thereof
SI1991263T1 (sl) 2006-03-01 2015-03-31 Aduro Biotech Listeria spremenjena z inĹľeniringom ter postopki za njenjo uporabo
BRPI0720342A2 (pt) * 2006-10-04 2018-09-18 Janssen Pharmaceutica N.V. preparado de células apresentadoras de antígenos artificiais e seu uso em terapias celulares.
US10596387B2 (en) * 2007-04-08 2020-03-24 Immunolight, Llc. Tumor imaging with X-rays and other high energy sources using as contrast agents photon-emitting phosphors having therapeutic properties
WO2008156813A1 (en) * 2007-06-20 2008-12-24 Uvcleaning Systems, Inc. Ultraviolet photoreactor for the purification of fluids
EP2008669A1 (en) 2007-06-22 2008-12-31 Maco Pharma S.A. Irradiation apparatus for inactivating pathogens and/or leukocytes in a biological fluid and process
EP2175889A1 (en) 2007-07-02 2010-04-21 CaridianBCT Biotechnologies, LLC Apparatus for photo reduction of contaminants in blood and blood products with calibration means
BRPI0911176B8 (pt) 2008-04-09 2021-05-25 Cerus Corp método de tratar uma composição de célula vermelha sanguínea, composição de célula vermelha sanguínea, e método de reduzir a desidratação em uma composição de célula vermelha sanguínea
CN106421864A (zh) * 2009-01-29 2017-02-22 S·E·内斯特尔 用于在空气和表面中产生高水平消毒作用的改善的方法和设备
US8715920B2 (en) 2010-07-27 2014-05-06 Biovec Transfusion, Llc Composition for preserving platelets during photosensitization
WO2011119950A2 (en) * 2010-03-26 2011-09-29 Aquionics, Inc. Ultraviolet disinfection of oil field process water
TWI518736B (zh) * 2010-03-31 2016-01-21 Ａｔｓ自動模具系統股份有限公司 光產生系統及其方法
WO2012071135A2 (en) 2010-11-23 2012-05-31 Biovec Transfusion, Llc Methods for removing pathogens from a platelet preparation
US9024292B2 (en) 2012-06-02 2015-05-05 Xiaohang Li Monolithic semiconductor light emitting devices and methods of making the same
CN203017432U (zh) * 2013-01-21 2013-06-26 中国人民解放军总医院 一种流动式血浆病毒灭活设备
WO2014131115A1 (en) 2013-03-01 2014-09-04 Klox Technologies Inc. Phototherapeutic device, method and use
US9415126B2 (en) * 2013-05-23 2016-08-16 Sensor Electronic Technology, Inc. Reflective transparent optical chamber
US20140353519A1 (en) * 2013-05-28 2014-12-04 ELKO Electronic Products Corp. Attached germicidal lamp assembly
JP2017077247A (ja) * 2014-03-07 2017-04-27 国立大学法人東京農工大学 ノロウイルスの不活性化方法、ノロウイルス不活性化用発光ダイオード、およびノロウイルスの不活性化装置
EP3194576B1 (en) 2014-07-23 2020-11-18 Cerus Corporation Methods for preparing platelet products
WO2016057965A1 (en) 2014-10-10 2016-04-14 Cerus Corporation Compositions and methods for treating viral hemorrhagic fever
ES2980387T3 (es) 2014-10-17 2024-10-01 Gambro Lundia Ab Método para proporcionar datos de funcionamiento a un aparato médico de procesamiento de fluidos usando un accesorio médico, y un accesorio médico
BR112017015159A2 (pt) 2015-01-16 2018-01-23 Cerus Corp preparação e uso de produtos plaquetários
US9937274B2 (en) 2015-03-18 2018-04-10 GE Lighting Solutions, LLC Light disinfection system and method
WO2016210374A1 (en) 2015-06-26 2016-12-29 Cerus Corporation Cryoprecipitate compositions and methods of preparation thereof
WO2017001561A1 (en) 2015-07-02 2017-01-05 Gambro Lundia Ab Systems and methods including a human-shaped graphical element
US20170014538A1 (en) 2015-07-14 2017-01-19 Juha Rantala LED structure and luminaire for continuous disinfection
US20170028121A1 (en) * 2015-07-31 2017-02-02 Fenwal, Inc. Irradiation device for biological fluids
WO2017062260A2 (en) * 2015-10-02 2017-04-13 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Inactivation of pathogens in ex vivo blood products in storage bags using visible light
CA3003097A1 (en) 2015-10-23 2017-04-27 Cerus Corporation Plasma compositions and methods of use thereof
CN108697738A (zh) 2016-01-07 2018-10-23 塞鲁斯公司 用于制备血小板的系统和方法
JP6895426B2 (ja) 2016-03-23 2021-06-30 テルモ株式会社 光照射装置
CN109890426A (zh) 2016-10-24 2019-06-14 锋翔科技公司 生物灭活的系统和方法
US10751433B2 (en) 2016-11-28 2020-08-25 Fenwal, Inc. Systems and methods for controlling an irradiation device
JP2020503512A (ja) 2016-12-23 2020-01-30 シーラス コーポレイション 化合物結合基材を使用して、試験およびスクリーニングするためのシステムおよび方法
US20190321407A1 (en) 2016-12-31 2019-10-24 Cerus Corporation Compositions and methods for preparation of red blood cells
BR112019018273A2 (pt) 2017-03-03 2020-07-14 Cerus Corporation kits e métodos para preparação de composições de plaquetas inativadas por patógenos
EP3684774A1 (en) 2017-09-20 2020-07-29 Cerus Corporation Compositions and methods for pathogen inactivation of platelets
US11124750B2 (en) * 2017-09-30 2021-09-21 Sensor Electronic Technology, Inc. Ultraviolet irradiation of fluids
MX2021003180A (es) 2018-09-20 2021-05-14 Cerus Corp Métodos y kits para preparar sangre entera con inactivación de patógenos.
AU2020303972A1 (en) 2019-06-22 2022-02-10 Cerus Corporation Systems and methods for implementing treatment of biological fluids
EP3986499A2 (en) 2019-06-22 2022-04-27 Cerus Corporation Biological fluid treatment systems
EP3991179A1 (en) 2019-06-28 2022-05-04 Cerus Corporation System and methods for implementing a biological fluid treatment device
US20210038802A1 (en) 2019-08-09 2021-02-11 Fenwal, Inc. System and method for irradiating biological fluids
US11577016B2 (en) 2019-08-20 2023-02-14 Fenwal, Inc. System and method for irradiating biological fluids
IL302136A (en) 2020-10-19 2023-06-01 Cerus Corp Modular light fixture for biological fluid treatment system

Also Published As

Publication number Publication date
US20230226232A1 (en) 2023-07-20
AU2018395525B2 (en) 2023-09-14
EP3731960A1 (en) 2020-11-04
MX2023006058A (es) 2023-07-31
SG11202006158TA (en) 2020-07-29
KR20200115498A (ko) 2020-10-07
CN116571191A (zh) 2023-08-11
CN111770789A (zh) 2020-10-13
JP7311518B2 (ja) 2023-07-19
JP2023080160A (ja) 2023-06-08
WO2019133929A1 (en) 2019-07-04
BR112020013178A2 (pt) 2020-12-01
US11554185B2 (en) 2023-01-17
US20190209718A1 (en) 2019-07-11
AU2018395525A1 (en) 2020-07-30
EA202091602A1 (ru) 2020-10-19
IL275698B2 (en) 2024-08-01
TWI821233B (zh) 2023-11-11
IL275698B1 (en) 2024-04-01
CA3087253A1 (en) 2019-07-04
CO2020009340A2 (es) 2020-10-30
TW201940198A (zh) 2019-10-16
IL275698A (en) 2020-08-31
CN111770789B (zh) 2023-05-05
JP2021508539A (ja) 2021-03-11

Similar Documents

Publication Publication Date Title
MX2023006058A (es) Sistemas y metodos para tratar fluidos biologicos.
MX2017001587A (es) Terapia de combinacion para tratar un paramixovirus.
MX2020004060A (es) Metodos para el tratamiento de infeccion de hepatitis b.
GEP20247583B (en) Methods for treating condi tions associated with masp-2 dependent complement activation
MX2021010460A (es) Metodo de tratamiento con tradipitant.
BR112017014481A2 (pt) máquinas de tratamento com fluido médico e sistemas e métodos relacionados.
GB201716987D0 (en) Pump, and fluid control device
EA201991818A1 (ru) Лечение рака
GB201509210D0 (en) Antimicrobial preparations, methods for preparing the same and uses thereof to combat microorganisms.
MX2019000232A (es) Deteccion de flujo de fluidos.
IL289014A (en) Biological fluid treatment systems
EP3252019A4 (en) Method for treating wastewater, and activator for treating wastewater
MX2017001490A (es) Combinaciones de farmacos para tratar mieloma multiple.
SG11201811429XA (en) Flow reactor
HK1253893A1 (zh) 用於流體滅菌的系統和方法
IL273819A (en) Devices, systems and methods for hatching (incubation) of bacteria
GB201708380D0 (en) Fluid treatment
IL254285A0 (en) Systems and methods for controlling electric fields in liquids, gases and bacteria
MX2018010919A (es) Procedimiento para el tratamiento termico de un producto plano de acero, producto plano de acero tratado termicamente asi como su uso.
MX2017001929A (es) Activacion del factor x.
SG11202104595PA (en) Fluid pump assemblies and kits, and related methods
TH1501007754A (th) วิธีการสำหรับการปฏิบัติงานชุดเครื่องสเตอริไลเซชั่นต่อเนื่อง, ชุดเครื่องสเตอริไลเซชั่นต่อเนื่อง, ระบบการหมัก และ ระบบการหมักต่อเนื่อง
UA93916U (uk) Система повного очищення робочої рідини в гідроциліндрі і трубопроводах
AU2016903999A0 (en) Sterile IV fluid concept
GB201616964D0 (en) Fluid treatment system